Online: | |
Visits: | |
Stories: |
by Karl Denninger
Market-Ticker.org
There’s a new Cholesterol drug on the market from Regeneron that is supposed to low cholesterol in those people who either can’t take statins (because of their side effects) or can’t take enough of them (for the same reason.)
The problem with this drug is that the screamers are all still talking about how cholesterol is the cause of problems in the body and the Regeneron CEO is on the boob this morning touting his “invention.”
The problem is that the evidence doesn’t point this way; cholesterol is not only necessary for all animal life the “lipid hypothesis” was known to be flawed (if not entire bogus) 50 years ago when it was first pushed on the public!
Continue Reading at Market-Ticker.org…